NEW YORK, Aug. 13 (GenomeWeb News) –  Physiome Sciences of Princeton, NJ, today announced that it will acquire Predix Pharmaceuticals of Woburn, Mass.

Physiome will acquire Predix in exchange for 30 percent of the combined equity of the two firms.  The combined entity will will be headquartered in Woburn, Mass., and will be named Predix Pharmaceuticals. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.